Oncodesign Services

Oncodesign Services is a contract research organization (CRO) based in Dijon, France, that specializes in drug discovery and preclinical services aimed at developing innovative therapies for oncology, inflammation, and infectious diseases. Established in 1995, the company employs a team of 230 professionals across France, Canada, and the United States. Oncodesign Services supports its clients by offering a comprehensive suite of capabilities, including medicinal chemistry, drug metabolism and pharmacokinetics (DMPK), pharmacological imaging, bioanalysis, and both in vivo and in vitro pharmacology. The organization collaborates with pharmaceutical companies, biotechnology firms, public research institutions, and investment groups to address critical gaps in healthcare innovation. By leveraging its expertise in precision medicine and advanced technological platforms, Oncodesign Services aims to enhance the efficacy of treatments and reduce therapeutic failures, ultimately contributing to the advancement of new therapeutic and diagnostic tools.